Table 1.
Baseline characteristics of clinic, angiography and laboratory.
| Coronary complexity | P value | ||||
|---|---|---|---|---|---|
| 0 (n=148) | 1 (n=114) | 2 (n=121) | 3 (n=130) | ||
| Male | 63 (42.6%) | 96 (84.2%) | 94 (77.7%) | 99 (76.2%) | <0.001 |
| Age | 56.0±9.14 | 57.5±12.1 | 60.6±12.0 | 64.1±12.1 | 0.423 |
| Hypertension (%) | 22 (24.86%) | 50 (20.16%) | 70 (28.22%) | 128 (51.63%) | <0.001 |
| Diabetes (%) | 20 (13.5%) | 23 (20.2%) | 29 (24.0%) | 44 (33.8%) | <0.001 |
| Alcohol intake (%) | 22 (14.9%) | 29 (25.4%) | 20 (16.5%) | 19 (14.6%) | 0.090 |
| Smoking (%) | 35 (23.6%) | 61 (53.5%) | 71 (58.7%) | 76 (58.5%) | <0.001 |
| TC (mmol/L) | 4.71±0.89 | 4.61±0.93 | 4.73±1.12 | 4.66±1.24 | 0.823 |
| TG (mmol/L) | 1.66±1.12 | 1.60±0.95 | 1.85±1.49 | 1.79±1.30 | 0.392 |
| LDL-C (mmol/L) | 2.89±0.75 | 2.94±0.85 | 3.01±0.99 | 3.02±0.99 | 0.549 |
| HDL-C (mmol/L) | 1.09±0.30 | 1.01±0.33 | 0.97±0.31 | 0.92±0.26 | <0.001 |
| ApoAI (mg/L) | 1.30 (1.15~1.44) | 1.14 (1.03~1.3) | 1.16 (1.0~1.34) | 1.14 (1.03~1.33) | <0.001 |
| ApoB (mg/L) | 0.82 (0.69~0.99) | 0.88 (0.76~1.0) | 0.83 (0.69~1.04) | 0.83 (0.71~1.02) | 0.058 |
| Lp(a) (mg/L) | 160 (101~322) | 187 (91~332) | 187 (65~302) | 167 (58~304) | 0.548 |
| HsCRP (mg/L) | 2.05 (1~8) | 8 (1.65~29) | 7 (2~25.9) | 8.85 (3.7~23.8) | <0.001 |
| ALT (U/L) | 18.5 (13.8~27.3) | 32.5 (18~57.5) | 34.5 (18.3~54.5) | 32 (23~50) | <0.001 |
| GGT (U/L) | 22 (15~37) | 23 (16~49) | 24 (17~47) | 30 (20~41.5) | 0.003 |
ALT – alanine aminotransferase; ApoAI – apolipoprotein AI – ApoB, apolipoprotein B; GGT – gamma-glutamyl transferase; HDL-C – high-density lipoprotein cholesterol; HsCRP – high sensitivity C reactive protein; LDL-C – low-density lipoprotein cholesterol; Lp(a) – lipoprotein (a); TC – total cholesterol; TG – triacylglycerol.